India bears one of the highest epilepsy burdens globally, with nearly 10 million cases. Yet, effective management remains elusive for 30-40% due to dosage issues. TDM bridges this gap by providing real-time data for personalized therapy.

‘The beauty of TDM is its precision,’ says AIIMS Neurology Head. ‘We can now fine-tune medications based on actual blood levels, not guesswork.’ The program launched quietly but has already drawn hundreds seeking relief.

Available Monday to Saturday at AIIMS’s specialized clinic, the test requires no advance booking—just show up with your prescription. Results are delivered within 48 hours, enabling swift treatment adjustments.

Health Minister hailed the initiative as ‘a game-changer for chronic disease management.’ Private labs charge ₹2,000-5,000 per test; AIIMS offers it free, removing financial barriers entirely.

Patient testimonials flood in: ‘After years of erratic seizures, TDM changed everything,’ recounts a Delhi resident. Support groups are spreading the word rapidly.

As AIIMS expands this service, it underscores government commitment to equitable healthcare. Epilepsy patients, take note—this could be your path to seizure-free living.